Enfanos

Enfanos is a private, early-stage biotech firm leveraging proprietary mass spectrometry-based platforms to create reagents and methods for enzyme activity assays, with a strong focus on lysosomal storage disorders and newborn screening research. Originating from the renowned Gelb laboratory at the University of Washington, the company commercializes over two decades of academic innovation. Its business model is primarily service and product-based, providing essential tools to research and diagnostic labs. While currently in a pre-revenue or early-revenue stage, Enfanos has established a key partnership with Waters Corporation to advance its technology applications.

Proprietary mass spectrometry-based multiplex assays for enzyme activity using custom synthetic substrates and internal standards, optimized for analysis from dried blood spots.

Enfanos competes with large reagent suppliers (e.g., PerkinElmer, Thermo Fisher) who offer broader newborn screening solutions and with academic labs that develop in-house methods. Its differentiation lies in its specialized, high-plex expertise originating from the Gelb lab and its focus on creating research tools that bridge the gap to clinical diagnostics.